العلاقة: |
1.(a)Memon,M.I.;Memon,M.A.J.Viral.Hepat.2002,9,84(b)Moradpour,D.;Cerny,A.;Heim,M.H.;Blum,H.E. Swiss Med Weekly 2001,131,291 2.For a review of HCV epidemiology, pathogenesis, and clinical treatment, see:(a)Lauer, G. M.;Walker, B. D. N. Engl. J.Med. 2001,345,41;(b)Di Bisceglie, A. M. Lancet 1998, 351,351 3.For a clinical overview of HCV, see:Strader, D. B.;Seeff, L. B. ILAR J. 2001,42,107 4.Shirota, Y. et al. Hepatitis C virus (HCV) NS5A binds RNAdependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J. Biol. Chem. 277, 11149–11155 (2002) 5. Tan SL, Pause A, Shi Y, Sonenberg N. Hepatitis C therapeutics: current status and emerging strategies. Nat Rev Drug Discov. 2002 Nov;1(11):867-81 6. Friebe, P., Lohmann, V., Krieger, N. & Bartenschlager, R. Sequences in the 5′?nontranslated region of hepatitis C virus required for RNA replication. J. Virol. 2001 75, 12047–12057 7. Reed, K. E. & Rice, C. M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Hep. C Viruses 2000 242, 55–84 7.Reed, K. E. & Rice, C. M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Hep. C Viruses 2000 242, 55–84 8. Shirota, Y. et al. Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J. Biol. Chem. 2002 277, 11149–11155 9. Pileri, P. et al. Binding of hepatitis C virus to CD81. Science 1998 282, 938–941 Monazahian, M. et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 1999 57,223–229 10. Monazahian, M. et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 1999 57,223–229 11. Agnello, V., Abel, G., Elfahal, M., Knight, G. B. & Zhang, Q. X. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 1999 96, 12766–12771 12. Bartenschlager, R. & Lohmann, V. Replication of hepatitis C virus. J. Gen. Virol. 2000 81, 1631–1648 13. Bukh, J., Miller, R. H. & Purcell, R. H. Genetic heterogeneity of hepatitis C virus — quasispecies and genotypes. Semin.Liv. Dis. 1995 15, 41–63 14.www.prn.org/./models/ img_pgs/hcv.3d.med.htm 15.www.genelabs.com/ research/antiviral.html 16. http://www.hopkins-gi.org/pages/latin/templates/index.cfmTest 17.Kolykhalov, A. A., Mihalik, K., Feinstone, S. M. & Rice, C. M.Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J. Virol. 74, 2046–2051 (2000) 18.Kolykhalov, A. A. et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277, 570–574 (1997). 19. Leveque, V. J.-P. & Wang, Q. M. RNA-dependent RNA polymerase encoded by hepatitis C virus: biomedical applications. Cell. Mol. Life Sci. 59, 909–919 (2002). 20. http://dock.compbio.ucsf.edu/DOCK_5/index.htmTest 21. http://sw16.im.med.umich.edu/software/xtool/manual/trouble.htmlTest 22. http://www.rcsb.org/pdbTest/ 23. 3-(4-AMINO-2-TERT-BUTYL-5-METHYL-PHENYLSULFANYL)- 6-CYCLOPENTYL-4-HYDROXY-6-[2-(4-HYDROXY-PHENYL)- ETHYL]-5,6-DIHYDRO-PYRAN-2-ONE 24. Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California 92121 Received 14 January 2003/Accepted 2 April 2003 25. Ago, H., T. Adachi, A. Yoshida, M. Yamamoto, N. Habuka, K. Yatsunami, and M. Miyano. 1999. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure 7:1417–1426. 26. Bressanelli, S., L. Tomei, A. Roussel, I. Incitti, R. L. Vitale, M. Mathieu, R. De Francesco, and F. A. Rey. 1999. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc. Natl. Acad. Sci. USA 96:13034–13039. 27. Lesburg, C. A., M. B. Cable, E. Ferrari, Z. Hong, A. F. Mannarino, and P. C. Weber. 1999. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat. Struct. Biol. 6:937–943. 28. Labonte, P., V. Axelrod, A. Agarwal, A. Aulabaugh, A. Amin, and P. Mak. 2002. Modulation of hepatitis C virus RNA-dependent RNA polymerase activity by structure-based site-directed mutagenesis. J. Biol. Chem. 277:38838–38846. 29. Qin, W., H. Luo, T. Nomura, N. Hayashi, T. Yamashita, and S. Murakami. 2002. Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase. J. Biol. Chem. 277:2132–2137. 30. Wang, Q. M., M. A. Hockman, K. Staschke, R. B. Johnson, K. A. Case, J. Lu, S. Parsons, F. Zhang, R. Rathnachalam, K. Kirkegaard, and J. M. Colacino. 2002. Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNA-dependent RNA polymerase. J. Virol. 76:3865–3872. 31. Yamashita, T., S. Kaneko, Y. Shirota, W. Qin, T. Nomura, K. Kobayashi, and S. Murakami. 1998. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the Cterminal region. J. Biol. Chem. 273:15479–15486. 32. Bressanelli, S., L. Tomei, F. A. Rey, and R. De Francesco. 2002. Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. J. Virol. 76:3482–3492. 33. (2Z)-2-(BENZOYLAMINO)-3-[4-(2-BROMOPHENOXY)PHENYL]- 2-PROPENOIC ACID 34. Jeffrey A. Pfefferkorn, Meredith L. Greene, Richard A. Nugent, Rebecca J. Gross, Mark A. Mitchell, Barry C. Finzel, Melissa S. Harris, Peter A. Wells, John A. Shelly, Robert A. Anstadt, Robert E. Kilkuskie, Laurice A. Kopta and Francis J. Schwende . Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid. Bioorganic & Medicinal Chemistry Letters 15 (2005) 2481–2486. 35. (a) Jacob-Molina, A.; Ding, J.; Nanni, R. G.; Clark, A. D.; Lu, X.; Tantillo, C.; Williams, R. L.; Kamer, G.; Ferris, A. L.; Clark, P.; Hizi, A.; Hughes, S. H.; Arnold, E. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6320; (b) Huang, H.; Chopra, R.; Verdine, G. L.; Harrison, S. C. Science 1998, 282, 1669. 36. Jeffrey A. Pfefferkorn, Richard Nugent, Rebecca J. Gross, Meredith Greene, Mark A. Mitchell, Matthew T. Reding, Lee A. Funk, Rebecca Anderson, Peter A. Wells, John A. Shelly, Robert Anstadt, Barry C. Finzel, Melissa S. Harris, Robert E. Kilkuskie, Laurice A. Kopta and Francis J. Schwendea.Inhibitors of HCV NS5B polymerase. Part 2:Evaluation of the northern region of (2Z)-2-benzoylamino-3-(4-phenoxy-phenyl)-acrylic acid. Bioorganic & Medicinal Chemistry Letters 15 (2005) 2812–2818.; http://nthur.lib.nthu.edu.tw/dspace/handle/987654321/30924Test |